These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11779599)

  • 21. Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.
    van Wely M; Westergaard LG; Bossuyt PM; van der Veen F
    Fertil Steril; 2003 Nov; 80(5):1086-93. PubMed ID: 14607553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery rates following IVF treatment, using two recombinant FSH preparations for ovarian stimulation.
    Harlin J; Aanesen A; Csemiczky G; Wramsby H; Fried G
    Hum Reprod; 2002 Feb; 17(2):304-9. PubMed ID: 11821268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two recombinant follicle-stimulating hormone preparations in in-vitro fertilization: a randomized clinical study.
    Tulppala M; Aho M; Tuuri T; Vilska S; Foudila T; Hakala-Ala-Pietilä T; Moilanen J; Bützow T; Kaukoranta S; Söderström-Anttila V; Siegberg R; Suikkari AM; Hovatta O
    Hum Reprod; 1999 Nov; 14(11):2709-15. PubMed ID: 10548606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK.
    Daya S; Ledger W; Auray JP; Duru G; Silverberg K; Wikland M; Bouzayen R; Howles CM; Beresniak A
    Hum Reprod; 2001 Dec; 16(12):2563-9. PubMed ID: 11726575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-acting FSH versus daily FSH for women undergoing assisted reproduction.
    Pouwer AW; Farquhar C; Kremer JA
    Cochrane Database Syst Rev; 2012 Jun; (6):CD009577. PubMed ID: 22696386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Health economic consequences of the choice of follicle stimulating hormone alternatives in IVF treatment].
    Poulsen PB; Højgaard A; Quartarolo JP
    Ugeskr Laeger; 2007 Apr; 169(14):1313-7. PubMed ID: 17437694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction.
    Daya S
    Fertil Steril; 2002 Apr; 77(4):711-4. PubMed ID: 11937121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands.
    Fragoulakis V; Pescott CP; Smeenk JM; van Santbrink EJ; Oosterhuis GJ; Broekmans FJ; Maniadakis N
    Appl Health Econ Health Policy; 2016 Dec; 14(6):719-727. PubMed ID: 27581117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment.
    Yong PY; Brett S; Baird DT; Thong KJ
    Fertil Steril; 2003 Feb; 79(2):308-15. PubMed ID: 12568839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy and cost-effectiveness of HP-human FSH (Fostimon®) versus rFSH (Gonal-F®) in IVF-ICSI cycles: a meta-analysis.
    Gerli S; Bini V; Favilli A; Di Renzo GC
    Gynecol Endocrinol; 2013 Jun; 29(6):520-9. PubMed ID: 23356335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.
    Out HJ; Mannaerts BM; Driessen SG; Bennink HJ
    Hum Reprod; 1995 Oct; 10(10):2534-40. PubMed ID: 8567765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction.
    Lloyd A; Kennedy R; Hutchinson J; Sawyer W
    Fertil Steril; 2003 Nov; 80(5):1108-13. PubMed ID: 14607557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone.
    Esposito MA; Barnhart KT; Coutifaris C; Patrizio P
    Fertil Steril; 2001 Mar; 75(3):519-24. PubMed ID: 11239535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in assisted reproduction techniques in the Spanish public health care system.
    Romeu A; Balasch J; Ruiz Balda JA; Barri PN; Daya S; Auray JP; Duru G; Beresniak A; Peinado JA
    J Assist Reprod Genet; 2003 Aug; 20(8):294-300. PubMed ID: 12948090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH: a retrospective case- controlled analysis.
    Ravhon A; Lavery S; Aurell R; Trew G; Margara R; Winston R
    Fertil Steril; 2001 May; 75(5):920-5. PubMed ID: 11334903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): a comparative study.
    Fisch B; Avrech OM; Pinkas H; Neri A; Rufas O; Ovadia J; Loumaye E
    J Assist Reprod Genet; 1995 Jan; 12(1):26-31. PubMed ID: 7580006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality.
    Selman HA; De Santo M; Sterzik K; Coccia E; El-Danasouri I
    Fertil Steril; 2002 Nov; 78(5):1061-7. PubMed ID: 12413994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of recombinant FSH and urinary-derived gonadotrophins for IVF or ICSI.
    van Wely M; van der Veen F
    Hum Reprod; 2003 Jul; 18(7):1554-5; author reply 1555-6. PubMed ID: 12832388
    [No Abstract]   [Full Text] [Related]  

  • 39. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FSH treatment in infertile males candidate to assisted reproduction improved sperm DNA fragmentation and pregnancy rate.
    Garolla A; Ghezzi M; Cosci I; Sartini B; Bottacin A; Engl B; Di Nisio A; Foresta C
    Endocrine; 2017 May; 56(2):416-425. PubMed ID: 27465288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.